)

Kiniksa Pharmaceuticals International (KNSA) investor relations material
Kiniksa Pharmaceuticals International Wells Fargo 20th Annual Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and growth trajectory
Focused on value creation with a commercialized product, Arclis, showing strong revenue growth since its 2021 launch, reaching $156.8M in Q2 and guiding $625M–$640M for 2025.
Penetration into the target patient population is about 15%, indicating significant room for expansion.
Development pipeline includes KPL-387 (monthly liquid formulation, auto-injector) in Phase II/III, aiming for market entry in 2028–2029, and 1161, a quarterly antibody targeting IL-1 alpha and beta.
Arclis commercialization and market dynamics
Arclis is the first and only FDA-approved therapy for recurrent pericarditis, with a broad label and growing prescriber base (over 3,475 prescribers as of Q2).
Patient education, physician outreach, and digital strategies, including AI, are driving adoption.
Medicare Part D changes led to a one-time patient bolus, with ongoing monitoring of affordability and access.
Average treatment duration is 30 months, with 45% of patients restarting therapy after stopping.
Pipeline development and clinical strategy
KPL-387 targets monthly dosing with strong physician and patient preference; Phase II data expected in 2026, with market entry targeted for 2028–2029.
Phase I data show sustained drug levels and a safety profile consistent with IL-1 inhibition.
1161 is in preclinical development, aiming for quarterly dosing and broader auto-inflammatory indications.
Next Kiniksa Pharmaceuticals International earnings date

Next Kiniksa Pharmaceuticals International earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage